4'-Methoxychalcone
CAS 959-23-9
4'-Methoxychalcone (CAS 959-23-9) is a pharmaceutical compound with 6 bioactivity targets and 0 adverse event associations.
Compound Identity
Matched identifiers and naming fields for the pharmaceutical compound record.
Cross-Reference to Cosmetics
Same-CAS ingredient record found in the cosmetics vertical.
Bioactivity & Target Interactions
Target-level activity records with assay counts, activity type, and measured value where present.
| Target | Activity | Value | Assays | Organism |
|---|---|---|---|---|
| - | IC50 | 37662.72625 nM | 15 | - |
| - | Potency | 23224.96 nM | 10 | - |
| - | GI50 | 8150 nM | 6 | - |
| - | EC50 | 38200 nM | 5 | - |
| - | Ki | 13 10^3nM | 1 | - |
| - | Ki | 21.9 nM | 1 | - |
Frequently Asked Questions
Short answers generated only from the same visible source-linked rows on this page.
What is 4'-Methoxychalcone used for in pharmaceutical contexts?
4'-Methoxychalcone (CAS 959-23-9) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.
What are the known adverse events for 4'-Methoxychalcone?
No adverse-event association or SIDER side-effect rows are rendered for 4'-Methoxychalcone in this page query. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.
Is 4'-Methoxychalcone also used in cosmetics?
Yes. The ingredients table has a same-CAS cosmetic profile for 4'-Methoxychalcone with EU status "permitted".
What clinical phase is 4'-Methoxychalcone in?
No phase 1-4 clinical development badge is rendered for 4'-Methoxychalcone because the matched compound identifier rows do not contain a max-phase value.